Rabies Antiserum IP About
Equirab Rabies Antiserum IP, marketed by Bharat Serums and Vaccines Ltd., stands as a towering solution for post-exposure prophylaxis against rabies. This sterile, ready-to-use injectable is suitable for all age groups, offering pivotal protection through immediate passive immunity after suspected animal bites. Compliant with IP standards, Equirab receives enviable and favorable reviews for its reliability and safety. Competitive pricing and efficient distribution make it a trusted choice-shop now for a product with proven market value, ensuring peace of mind when rapid response is crucial.
Competitive Advantages & Leading Applications
Rabies Antiserum IP distinguishes itself with its pivotal role in immediate, life-saving immunity following rabies exposure. Its single-use vial ensures optimal sterility, ready-to-administer convenience, and full compliance with Indian Pharmacopoeia standards. Suitable for both prophylactic and therapeutic use, it's favored in clinical settings for rapid containment of the virus. The enviable reliability and favorable reviews underscore its commercial value to healthcare providers, traders, exporters, and suppliers throughout India.
Domestic Market Value, Supply & Seamless Exchange
Rabies Antiserum IP commands towering market value across India due to its extensive reach and trusted efficacy. Suppliers guarantee a steady supply ability, supporting prompt order completion for both private and public healthcare facilities. Payment terms are flexible to facilitate smooth exchanges, catering to high-volume domestic markets. With competitive pricing and accessible distribution, Equirab cements its pivotal status in safeguarding communities nationwide.
FAQ's of Rabies Antiserum IP:
Q: How should Equirab Rabies Antiserum IP be administered?
A: Equirab Rabies Antiserum IP must be administered either intramuscularly or via local infiltration at the site of the bite by a qualified medical professional, according to prescribed dosage guidelines based on body weight.
Q: What are the main benefits of using Rabies Antiserum IP?
A: This antiserum provides immediate passive immunity against the rabies virus following exposure, making it pivotal in preventing disease progression during the critical window after a bite or suspected exposure.
Q: When is Rabies Antiserum IP indicated for use?
A: Rabies Antiserum IP is indicated for post-exposure prophylaxis following suspected or confirmed rabies exposure, particularly after animal bites or scratches.
Q: Where can healthcare professionals order Equirab for clinical use?
A: Healthcare professionals and suppliers can order Equirab Rabies Antiserum IP from licensed medical distributors, traders, or directly through exporters affiliated with Bharat Serums and Vaccines Ltd. across India.
Q: What storage conditions are recommended for this antiserum?
A: The product must be stored at 2C to 8C, kept away from light, and never frozen to maintain its potency and sterility until order completion and administration.
Q: Who should avoid using Rabies Antiserum IP?
A: Individuals with known hypersensitivity to equine serum proteins should not use equine-derived Rabies Antiserum IP due to the risk of allergic reactions.